Archive: 27/04/2015

Mylan rebuffs Teva again; calls bid low, insincere

Generic drug company Mylan rejected for the second time Monday a $40.1 billion takeover offer from Israeli pharmaceutical power Teva, just days after Mylan's own bid for rival Perrigo was rebuffed.

page 5 from 9